J. Lerpiniere

发表

The HgCl2-promoted guanylation reaction: The scope and limitations

S. Ko, C. Levallet, J. Lerpiniere, 1997 .

Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.

A. Lawrence, R. Gillespie, C. Dourish, 2008, Bioorganic & medicinal chemistry letters.

Enantioselective synthesis of goniobutenolides A and B

S. Ko, J. Lerpiniere, 1995 .

Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines.

R. Gillespie, C. Dourish, D. S. Williamson, 2008, Bioorganic & medicinal chemistry letters.

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models.

S. Ko, L. Urbán, M. Lemaire, 1998, Journal of medicinal chemistry.

An approach to the synthesis of (–)-lipstatin by Wittig reaction and Lewis acid-promoted [2 + 2] cycloaddition

P. Kocieňski, J. Pons, J. Lerpiniere, 1993 .

An Efficient Synthesis of Internal Guanidines

A. Christofi, S. Ko, J. Lerpiniere, 1995 .

Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson’s disease

C. Dourish, S. Weiss, J. Lerpiniere, 2003, Neurology.

Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.

A. Knight, R. Gillespie, D. Surry, 2009, Journal of medicinal chemistry.

Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.

A. Lawrence, R. Gillespie, S. Ward, 2008, Bioorganic & medicinal chemistry letters.

Antagonists of the human A(2A) receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides.

R. Gillespie, A. Jordan, J. Lerpiniere, 2009, Bioorganic & medicinal chemistry letters.